Home > Insider Trading > Filing (0001562180-21-004818)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1636422	Health Catalyst Inc.	HCAT	Services-Computer Programming, Data Processing, Etc. (7370)	453337483

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780878	Linda Llewelyn	C/O Health Catalyst, Inc. 10897 South River Front Parkway, #300 South Jordan UT 84095	Chief People Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-07-01	1,100	$11.78	37,211	No	4	M	Direct
Common Stock	Acquisiton	2021-07-01	2,050	$10.80	39,261	No	4	M	Direct
Common Stock	Disposition	2021-07-01	2,699	$55.75	36,672	No	4	S	Direct
Common Stock	Disposition	2021-07-01	561	$56.43	36,111	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-07-01	1,100	$11.78	1,100	$11.78
Common Stock	Stock Option (Right to Buy)	Disposition	2021-07-01	2,050	$10.80	2,050	$10.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,454		2028-01-24	No	4	M	Direct
31,048		2028-09-27	No	4	M	Direct

Footnotes

The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1.
Represents the weighted average sale price of the shares sold ranging from $55.34 to $56.27 per share, inclusive.
Represents the weighted average sale price of the shares sold ranging from $56.37 to $56.54 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and footnote 2.
25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022.
25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.